Philipp Schatz,
Head of Biomarker Program
Philipp Schatz, Ph.D., is Head of Biomarker Program at Metanomics Health GmbH, a BASF Group Company, since 2012. Dr. Schatz has an in-depth understanding of biomarker discovery & validation, assay development, and commercialization. He oversees the Biomarker Program which provides metabolic biomarkers to support pharma-enabling and diagnostic applications in various indications such as, congestive heart failure, type 2 diabetes, neurodegenerative diseases and multiple oncological applications. Prior to Metanomics Health, Dr. Schatz worked for 12 years in the diagnostic industry. Dr. Schatz holds a M. Sc. in Biotechnology Engineering from the Technical University Berlin and a Ph.D. in epigenetics from the University of Saarland.
|
|
|
